These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 15155531
1. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, Johnson IT. Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531 [Abstract] [Full Text] [Related]
2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ. Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772 [Abstract] [Full Text] [Related]
3. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells]. Li JY, Yu JP, Luo HS, Yu BP, Tian G, Mei Q, Huang JA. Ai Zheng; 2002 Jun 15; 21(6):625-9. PubMed ID: 12452063 [Abstract] [Full Text] [Related]
4. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1). Vona-Davis L, Riggs DR, Jackson BJ, McFadden DW. J Surg Res; 2004 Jun 15; 119(2):143-8. PubMed ID: 15145696 [Abstract] [Full Text] [Related]
13. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A. Clin Cancer Res; 2003 May 15; 9(5):1885-97. PubMed ID: 12738747 [Abstract] [Full Text] [Related]
14. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN. Clin Cancer Res; 2001 Oct 15; 7(10):2998-3005. PubMed ID: 11595687 [Abstract] [Full Text] [Related]
15. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin. Konturek PC, Kania J, Burnat G, Hahn EG. J Physiol Pharmacol; 2006 Dec 15; 57 Suppl 12():15-24. PubMed ID: 17244951 [Abstract] [Full Text] [Related]
16. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. Chen PY, Long QC. Acta Pharmacol Sin; 2004 Jul 15; 25(7):943-9. PubMed ID: 15210070 [Abstract] [Full Text] [Related]
18. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ. J Gastroenterol Hepatol; 2004 Jun 15; 19(6):638-42. PubMed ID: 15151617 [Abstract] [Full Text] [Related]
19. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH. Anticancer Res; 2002 Jun 15; 22(4):2089-96. PubMed ID: 12174888 [Abstract] [Full Text] [Related]
20. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B. J Oral Pathol Med; 2004 Nov 15; 33(10):607-13. PubMed ID: 15482327 [Abstract] [Full Text] [Related] Page: [Next] [New Search]